Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

  1. Yang, J.C.H.
  2. Brose, M.S.
  3. Castro, G.
  4. Kim, E.S.
  5. Lassen, U.N.
  6. Leyvraz, S.
  7. Pappo, A.
  8. López-Ríos, F.
  9. Reeves, J.A.
  10. Fellous, M.
  11. Penault-Llorca, F.
  12. Rudzinski, E.R.
  13. Tabatabai, G.
  14. Vassal, G.
  15. Drilon, A.
  16. Trent, J.
Aldizkaria:
BMC Cancer

ISSN: 1471-2407

Argitalpen urtea: 2022

Alea: 22

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/S12885-022-09687-X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus